Publication Name	World Journal of Clinical Oncology
Manuscript ID	66754
Country	Argentina

Received	2021-04-04 23:19
Peer-Review Started	2021-04-04 23:23
First Decision by Editorial Office Director	2021-06-04 02:54
Return for Revision	2021-06-04 11:28
Revised	2021-06-14 14:49
Publication Fee Transferred
Second Decision by Editor	2022-02-14 05:31
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2022-02-16 07:35
Articles in Press	2022-02-16 07:35
Edit the Manuscript by Language Editor	2022-02-02 06:00
Typeset the Manuscript	2022-03-14 00:48
Publish the Manuscript Online	2022-03-24 09:40

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Evidence Review
Article Title	Evidence-based approach to the treatment of esophagogastric junction tumors
Manuscript Source	Invited Manuscript
All Author List	Francisco Schlottmann, María A Casas and Daniela Molena
Funding Agency and Grant Number
Corresponding Author	Francisco Schlottmann, MD, Surgeon, Department of Surgery, Hospital Alemán of Buenos Aires, Av. Pueyrredón 1640, Buenos Aires C1118AAT, Argentina. fschlottmann@hotmail.com
Key Words	Esophagogastric junction tumors; Esophageal adenocarcinoma; Esophagectomy; Gastrectomy; Chemotherapy; Chemoradiation
Core Tip	Management of patients with esophagogastric junction tumors is challenging. Several surgical approaches and systemic therapies are currently available to treat these patients. This evidence-based review will help determining the optimal treatment for this complex disease.
Publish Date	2022-03-24 09:40
Citation	Schlottmann F, Casas MA, Molena D. Evidence-based approach to the treatment of esophagogastric junction tumors. World J Clin Oncol 2022; 13(3): 159-167
URL	https://www.wjgnet.com/2218-4333/full/v13/i3/159.htm
DOI	https://dx.doi.org/10.5306/wjco.v13.i3.159

Full Article (PDF)	WJCO-13-159.pdf
Full Article (Word)	WJCO-13-159.docx
Manuscript File	66754_Auto_Edited-ZMG-Filipodia.docx
Answering Reviewers	66754-Answering reviewers.pdf
Audio Core Tip	66754-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	66754-Conflict-of-interest statement.pdf
Copyright License Agreement	66754-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	66754-Language certificate.pdf
Peer-review Report	66754-Peer-review(s).pdf
Scientific Misconduct Check	66754-CrossCheck.png
Scientific Misconduct Check	66754-Bing-Gong ZM-2.png
Scientific Editor Work List	66754-Scientific editor work list.pdf
CrossCheck Report	66754-CrossCheck report.pdf